Martine R. G.
- Country
- France
- Department
- Department of pulmonary diseases
Research Overview
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Progressive Pulmonary Fibrosis
- A Phase 2a Study to Evaluate the Safety and Efficacy of ABBV-142 in Adults with Idiopathic Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 286 of 406 partner sites.
Specializations
Pulmonary Fibrosis Research
The investigator specializes in the study of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), with particular focus on innovative therapeutic approaches. Their research encompasses evaluation of novel treatments for managing fibrotic lung conditions.
- Interstitial Lung Disease Management
- Fibrotic Disease Progression
- Treatment Response Assessment
Pulmonary Hypertension Studies
Extensive work in pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with COPD. The investigator evaluates various therapeutic interventions aimed at improving patient outcomes and exercise capacity.
- PAH Treatment Optimization
- Long-term Disease Management
- Therapeutic Response Monitoring
Respiratory Infections
Research focus includes the treatment of Mycobacterium avium complex pulmonary infections and evaluation of antimicrobial therapies. The investigator studies comparative effectiveness of different treatment approaches.
- Mycobacterial Disease Treatment
- Antimicrobial Therapy Assessment
- Treatment Protocol Development
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.